Likvor goes - UK
The unique LIKVOR CELDA®
SYSTEM is now available on the UK market and the
first system has been sent to a customer. In addition,
Likvor AB has signed a distribution
agreement with its first distributor for this region.
The system helps to restore normal life back to millions of
dementia patients with hydrocephalus diagnosis.
Likvor AB takes an important step out on the European market by
signing a distribution agreement for the UK market with Seren
Medical Ltd. Seren Medical is a company specializing in
sales, marketing, service and support of state-of-the-art medical
equipment.
The LIKVOR CELDA® SYSTEM is being successfully used
in leading neurological clinics in Sweden, Denmark and Finland.
Statistics show that 1 in 10 dementia patients suffer from an
undiagnosed or misdiagnosed condition known as treatable or
reversible dementia (NPH - normal pressure hydrocephalus). The
symptoms of NPH commonly include difficulty in walking, urinary
incontinence, and mild dementia. The condition generally manifests
in over 55 year-olds. In contrast to dementia, NPH can be treated
by means of a simple operation to give sufferers a completely new
lease on life. Studies indicate that approximately 1.4 million
patients in Europe, USA and Japan suffer from NPH.
Together with the fact that the LIKVOR CELDA® SYSTEM
is used for diagnose/exclude NPH patients from other dementia
diseases as Alzheimer or Parkinson's the LIKVOR CELDA®
SYSTEM is a very useful tool for investigating shunt function. It
can be used for diagnosis of existing shunts. By using the LIKVOR
CELDA® SYSTEM hospitals can make huge savings, in costs
as they reduce the number of shunt reoperations and in human
suffering.
Likvor is an Umeå based medical device company which has
developed a system to be used in neurological investigations. The
LIKVOR CELDA® SYSTEM is the result of over 30 years of
research at Umeå University and Umeå University Hospital assessing
cerebrospinal fluid (CSF) dynamics. Likvor is
marketing the LIKVOR CELDA® SYSTEM and LIKVOR
CELDA® TOOLS. Likvor continues to develop new methods
and devices in the area of CSF dynamics, together with the
researchers at Umeå University and Umeå University
Hospital.
Please contact Likvor directly for further information.
CEO, Maria Wallin Wållberg: +46 (0)70 588 6766, maria.wallinwallberg@likvor.com